FDA Enacts Class I Urgent Recall for Infusion Pump Firmware Due to Upstream Occlusion Sensor Anomalies
The FDA has classified a global recall of large-volume infusion pumps as Class I, warning that intermittent firmware sensor errors can cause unintended interruption of high-risk medication infusions.
The U.S. Food and Drug Administration has posted an urgent Class I recall notice regarding select serial numbers of large-volume smart infusion pumps distributed worldwide. Class I recalls indicate situations where exposure to a violative product carries a reasonable probability of serious adverse health consequences or death.
Root Cause Analysis
Internal engineering evaluations and post-market surveillance alerts identified that a timing vulnerability within firmware versions 4.2.1 through 4.3.0 may fail to recognize upstream air-in-line or pressure occlusion alarms during micro-dose vasopressor administration.
Action Steps for Biomedical Engineering Teams
- Immediately verify inventory against listed model identifiers and firmware builds.
- Isolate unverified infusion units from critical care and pediatric units.
- Apply manufacturer firmware patch v4.3.2 per field safety corrective action protocols.
- Report any adverse events or infusion discrepancies to FDA MedWatch Form 3500A.
This intelligence report was compiled and verified by the NewsKrez Editorial & Regulatory Intelligence Desk.
Automated 21 CFR Part 820 & ISO 13485 Verification
Explore Solution →